×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Shopping
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Vanda Pharmaceuticals up 15% as Future Pak sweetens bid
Seeking Alpha
Future Pak increases its acquisition offer for Vanda Pharmaceuticals, offering contingent value rights and a cash consideration of $7.75 per...
1 day ago
Vanda Pharma falls after posting Q1 loss
XM
... ** Shares of drug maker Vanda Pharmaceuticals VNDA.O fall 7.3% to $4.97 premarket. ** Late Wednesday, co posted Q1 loss of 7 cents/shr...
2 hours ago
FDA shoots down Vanda hearing request over Hetlioz rejection
Fierce Pharma
Vanda Pharmaceuticals has been waiting years for an FDA hearing to contest the agency's 2019 rejection of its sleep drug Hetlioz in jet lag...
2 months ago
Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder
PR Newswire
WASHINGTON, April 2, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug...
1 month ago
Vanda Pharmaceuticals up 15% as Future Pak sweetens bid
Seeking Alpha
Future Pak increases its acquisition offer for Vanda Pharmaceuticals, offering contingent value rights and a cash consideration of $7.75 per...
1 day ago
Vanda Pharmaceuticals shares jump 30% after FDA approval of Fanapt for bipolar I disorder
MarketWatch
Referenced Symbols ... Shares of Vanda Pharmaceuticals VNDA jumped 33% to $5.23 in post-market trading after the company said the Food and Drug...
1 month ago
Vanda Pharmaceuticals Inc (VNDA) Faces Revenue Decline Amid Patent Challenges and Generic ...
Yahoo Finance
Vanda Pharmaceuticals Inc (VNDA) Faces Revenue Decline Amid Patent Challenges and Generic ... · Revenue: Full year 2023 revenues decreased by 24...
3 months ago
Supreme Court Declines to Hear Vanda's Patent Obviousness Appeal
Patently-O
by Dennis Crouch. The Supreme Court has denied Vanda Pharmaceuticals' petition for certiorari, leaving in place a Federal Circuit decision...
2 weeks ago
Clarifying What's Obvious: Vanda Seeks Supreme Court Review of Whether Obviousness Requires Predictability or ...
Crowell & Moring LLP
Drug development in the United States is expensive and time-consuming, which makes pharmaceutical patents an important asset for...
3 months ago
Supreme Court will not hear D.C. biotech's patent infringement appeal - Washington Business Journal
The Business Journals
As a result, the company stands to lose revenue related to one of the three drugs it has on the market.
2 weeks ago